SC
RVMD icon

Steven Cohen’s Revolution Medicines RVMD Stock Holding History

Steven Cohen’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,600
Closed -$253K – 4506
2026
Q1 		$253K Buy
+2,600
New +$263K ﹤0.01% 3430

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Steven Cohen's RVMD Position: Q2 2026 in Review

Steven Cohen opened a new position in Revolution Medicines (RVMD) in Q2 2026: 60,276 shares worth $11.3M. The stake represents 0.01% of the portfolio and ranks #1206 among its holdings. This is a return to the name: Steven Cohen previously reported a position in RVMD as recently as Q4 2025.

Steven Cohen first reported a position in RVMD in Q2 2021 and has held it in 9 quarters since. The position peaked at $35.6M in Q4 2025. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Steven Cohen held 60,276 shares of Revolution Medicines worth $11.3M as of Q2 2026.
  • Revolution Medicines was a new Steven Cohen position in Q2 2026.
  • Revolution Medicines made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1206 holding.
  • Steven Cohen first reported a position in Revolution Medicines in Q2 2021 and has held it in 9 quarters since.
  • Steven Cohen's Revolution Medicines position peaked at $35.6M in Q4 2025.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.